Skip to main content

A shared-care model of obesity treatment for 3–10 year old children: Protocol for the HopSCOTCH randomised controlled trial



Despite record rates of childhood obesity, effective evidence-based treatments remain elusive. While prolonged tertiary specialist clinical input has some individual impact, these services are only available to very few children. Effective treatments that are easily accessible for all overweight and obese children in the community are urgently required. General practitioners are logical care providers for obese children but high-quality trials indicate that, even with substantial training and support, general practitioner care alone will not suffice to improve body mass index (BMI) trajectories. HopSCOTCH (the Shared Care Obesity Trial in Children) will determine whether a shared-care model, in which paediatric obesity specialists co-manage obesity with general practitioners, can improve adiposity in obese children.


Randomised controlled trial nested within a cross-sectional BMI survey conducted across 22 general practices in Melbourne, Australia.


Children aged 3–10 years identified as obese by Centers for Disease Control criteria at their family practice, and randomised to either a shared-care intervention or usual care.


A single multidisciplinary obesity clinic appointment at Melbourne’s Royal Children’s Hospital, followed by regular appointments with the child’s general practitioner over a 12 month period. To support both specialist and general practice consultations, web-based shared-care software was developed to record assessment, set goals and actions, provide information to caregivers, facilitate communication between the two professional groups, and jointly track progress.


Primary - change in BMI z-score. Secondary - change in percentage fat and waist circumference; health status, body satisfaction and global self-worth.


This will be the first efficacy trial of a general-practitioner based, shared-care model of childhood obesity management. If effective, it could greatly improve access to care for obese children.

Trial Registration

Australian New Zealand Clinical Trials Registry ACTRN12608000055303


Despite recent indications that the upward trend in childhood obesity is plateauing, its prevalence remains at historically high levels [1]. Although childhood obesity affects around 6% (approximately 200,000) of all Australian children, very few of them receive treatment from their general practitioner or paediatrician [2, 3]. Effective evidence-based treatments remain scarce and are generally only available to small proportions of seriously obese children through tertiary care settings. Whilst prevention must ultimately be the main goal, there are already a large number of obese children who urgently require effective treatment if the consequences for their adult health – such as heart disease and diabetes, psychological morbidity, and massive excess health care costs – are to be avoided.

So far, the only healthcare setting that is consistently documented to reproducibly improve the body composition and health of obese children is the specialist obesity clinic, generally involving lifestyle advice, motivation and feedback provided by a multidisciplinary team over a year or more. Mean reductions in body mass index (BMI) z-score sustained to at least 12 months are typically around 0.3 [4]; approximately 85% of children typically achieve at least some overall reduction in BMI z-score although only around 30% achieve the reduction of ≥0.5 [4, 5] that equates to definite reductions in fat mass [6] and quantifiable improvements in risk factors for heart disease and diabetes [4, 7]. Unfortunately, although intervention appears more successful for younger children, the caseload of specialist obesity clinics is often typically skewed towards adolescents with significant psychological, social and family dysfunction for whom treatment is less effective [4]. Furthermore, such clinics are inaccessible to almost all children. By our estimation the nine obesity clinics in children’s hospitals around Australia could see, at most, around 0.05% of affected Australian children each year, and it seems likely that other countries would have similar situations.

Therefore, as the only universally-accessible healthcare service available throughout childhood, general practice might seem the obvious healthcare setting to support the improvement, achievement and maintenance of healthy weight in children who are already overweight or obese. However, trials of obesity approaches in which treatment is initiated and carried out solely by general practitioners, with or without allied health services, have been extraordinarily disappointing to date both for adults [8] and children [912]. A new approach is therefore needed to augment the treatment of childhood obesity in primary care.

Nonetheless, there remain good reasons for optimism when considering general practice as a mode for the successful management of paediatric obesity. Firstly, this is where the majority of overweight/obese children present. In a study of 3000 Victorian primary school children, parents reported that 55% of overweight children had attended a GP once or twice in the preceding six months, and 22% three or more times [13]. In two subsequent randomised controlled trials, we have also shown that: (1) general practitioners can and do take up training to offer a series of structured consultations using strategies for family lifestyle change, (2) that they are able to systematically identify children in the overweight and obese categories, (3) that families are willing for their children to be screened for BMI and not only engage, but persist, with their general practitioner, and (4) that this approach does not appear to be harmful for overweight or mildly obese children [10, 14]. GPs are very clear that the management of childhood obesity falls within their role [15] and with training they can feel comfort and competent in this area [16].

The literature on shared-care approaches incorporating primary and specialist partnerships is relatively limited but encouraging in achieving similar [17, 18] or better [19] disease outcomes with important ancillary outcomes such as increased satisfaction [20] and reduced waiting times [21]. For instance, an adult rheumatoid arthritis trial demonstrated higher quality-adjusted life-years for the shared-care than the aggressive arm [18], while a shared-care intervention for patients newly diagnosed with cancer increased general practitioner contact and positively influenced patients’ attitudes toward the healthcare system [17]; in neither trial was the disease outcome poorer in the shared-care arm. However, few shared-care trials have focused on children, and none on childhood obesity.

Given the potential benefits of health information technology to general practice [22], the Australian government has prioritised its use and value [23] with the result that, by 2005, 80% had broadband access and nearly 90% used a computer for clinical purposes [24], and is most likely close to 100% as of 2011. Some health information technology features are already nearly universally (eg prescribing) or frequently (eg accessing patient educational material) used, but far fewer general practitioners (<20%) are accessing computerised clinical information or using online decision support during consultations [24]. It is clear that e-health has both promise and limitations [25] and that the potential will not be actualised without carefully designing e-health initiatives into the primary care process. Health information technology could present an excellent mechanism to enhance shared-care models.

The HopSCOTCH (Shared Care Obesity Trial in Children) randomised trial is the first to our knowledge to study the efficacy of a general-practitioner based, shared-care model in reducing obesity in children – a population relatively underserved by evidence-based approaches [26]. The intervention needs to be developed in such a way that it could be widely implemented with consistency and sustainability, but with relatively little training. Underpinning this would be a very practical software platform that would provide standalone guidance and information to GPs while also enhancing primary-specialty care partnerships. The software would also support continuing practice improvement activities and the individual practitioner feedback that has proved useful in many fields [27]. Essentially, we hope to replicate the effectiveness of the specialty obesity clinic in the general practice setting, with attention to feasibility, sustainability and a wider and more systematic availability.

Aims and hypothesises

The aim of the HopSCOTCH trial is to develop, implement and trial an innovative shared-care approach to manage childhood obesity. We will compare outcomes for 3–10 year old obese children randomised to a shared-care model (general practitioners working with paediatric obesity specialist, consisting of a paediatrician and dietician - ‘intervention’ group) with outcomes for those receiving usual patient-driven primary care (‘control’ group).

We hypothesise that:

  1. 1.

    Compared to the control group, the intervention children will demonstrate better outcomes at 15 months in terms of lower:

    1. i)

      Relative BMI, measured as a z-score (primary outcome)

    2. ii)

      Percentage body fat

    3. iii)

      Waist circumference

  2. 2.

    Compared to the control group, the intervention children will not show evidence of harm (ie poorer health status, body satisfaction, or global self-worth) at 15 months.

  3. 3.

    The intervention will be acceptable and feasible to (i) parents, (ii) general practitioners, (iii) general practice staff, and (iv) the obesity specialists.

Methods and Design

Approval and registration

The project is funded by the National Health and Medical Research Council of Australia (Project Grant 491212). It has been approved by the Royal Children’s Hospital Melbourne Human Ethics Committee (28017) and The University of Melbourne Human Research Ethics Committee (0827435).


HopSCOTCH is a randomised controlled trial of a shared-care intervention versus usual care in obese children (see Figure 1). The trial commenced in April 2008 and will run until December 2011. This period encompasses participant recruitment, baseline data collection, intervention delivery, follow up data collection (15 months post-recruitment, equating to approximately 12 months post-intervention) and data analysis.

Figure 1
figure 1

Graphical depiction of components of the HopSCOTCH trial.


Participants are (1) 120 children aged 3–10 years, identified as obese according to the United States Centres for Disease Control (CDC) charts (≥95th age- and sex-specific percentile) [28]; and (2) their parents. Children were identified through participating general practitioners (GPs).

GP recruitment and training

To recruit GPs, HopSCOTCH was widely advertised through the Royal Australian College of General Practitioners and the Victorian general practice research network ‘VicReN’ e-bulletins/newsletters. Personalised invitations were also sent to GPs who previously participated in the LEAP 1 and LEAP 2 trials [10, 29]. Of the 70 GPs who initially expressed interest, 35 GPs across 22 practices decided to take part.

GPs attended a 2½ hour group training session for instruction in the “stages of change” model [30] and training in brief, solution-focused family therapy [31]. GPs were shown role model scenarios of GPs using solution-focused therapy in consultations for healthy family lifestyle and given the opportunity to mimic these skills themselves with colleagues in role play scenarios designed by the research team. GPs also completed readings on current obesity management, followed by a brief online quiz to test their knowledge and training in measuring protocols. Those delivering the intervention received one-on-one training in how to use the specially designed shared-care software. GPs were provided with the following remuneration for their time and for bulk-billing all shared-care patients: $220 for attending the training sessions; $25 per child recruited from their practice; and $75 for GPs that saw shared-care patients five times and an additional $75 if they saw them eight or more times.

Recruitment of children

To recruit children, HopSCOTCH was publicised in participating practices through posters, brochures and practice staff. Trained general practice staff opportunistically offered to weigh and measure children using calibrated digital scales and rigid stadiometers supplied by the research team. Eleven practices also sent letters to all of their in-age children inviting them to attend a dedicated weigh and measure session run by the research team or practice staff at the practice. With parent assent, their contact details and child anthropometry data were then mailed or faxed to the research team. Upon receipt, the research team calculated each child’s BMI and BMI percentile. Provided parents had left contact details, ineligible children’s families were sent a letter informing them of their ineligibility, while eligible families were telephoned to propose participation in the trial. Interested eligible families were mailed a parent information sheet, consent form and parent baseline questionnaire. Upon receipt of the written informed consent and the parent baseline questionnaire, families were enrolled in the trial.

Inclusion and exclusion criteria

Inclusion criteria

Eligible families included children who met both the following requirements:

  1. 1)

    BMI ≥95th for age- and sex-specific percentile according to the CDC charts, placing them in the obese range; and

  2. 2)

    aged between 3 and 10 years (i.e. up to but not including their 11th birthday).

Exclusion criteria

Children were excluded if they met any of the following criteria:

  1. 1)

    receiving ongoing weight management in a secondary or tertiary care program;

  2. 2)

    a known endocrine or genetic cause for their obesity;

  3. 3)

    a major disability or health condition judged by parents and/or researchers to preclude meaningful participation;

  4. 4)

    their family did not speak sufficient English to complete questionnaires and participate in the trial.

Randomisation and blinding

Randomisation occurred via a concealed, computerised random number sequence stratified by general practitioner and pre-generated by the Clinical Epidemiology and Biostatistics Unit at the Royal Children’s Hospital. Once enrolled (i.e. on receipt of written informed consent and baseline questionnaire) a research assistant, who was not otherwise involved with the trial, randomised children to either the shared-care or usual-care arm. All families were advised of their child’s allocation by a mailed letter. All outcome measures were collected by researchers blinded to the child’s allocation status.

Intervention arm

Shared-care software

A web-based shared-care software was designed with the goals of 1) allowing the obesity specialists and GPs to collaborate and communicate closely in the care of their patients, 2) providing a structured yet efficient approach to weight management care, and 3) providing a mechanism that allows both GPs and specialists to record and track patient progress simultaneously. The software’s weight management care plan consists of five steps: 1) recording anthropometry, 2) reviewing BMI change using an online chart to plot and track BMI visually over time against percentile charts, 3) assessing and tracking progress and motivation, 4) reviewing care plan (i.e. issues and goals), and 5) providing educational resources.

The HopSCOTCH software, developed in collaboration with Pen Computer Systems Pty Ltd (PCS), was designed to support specialist and GP management of children with obesity and to facilitate communication of information between the health care providers involved. Specifically, the HopSCOTCH system provides notification and communication between providers of care, access to patient information for care team members via the shared web-based HopSCOTCH record, obesity assessment and management tools, and help in developing a detailed management plan and history. Printouts of plans, educational resources and patient summaries can also be obtained. HopSCOTCH is launched from a desktop application, the PrimaryCare Sidebar®, a proprietary product of PCS. The PrimaryCare Sidebar® sits on the right of the screen (by default) and contains a series of panels, each with links to a range of primary care software tools. The panels allow the tools to be grouped into logical areas of health care. The HopSCOTCH system is accessed via the PCS Linked CareTM panel.

Obesity specialist consultation

The shared-care intervention involved each family (at a minimum the index child and one parent/guardian) attending a single one-hour session at Melbourne’s Royal Children’s Hospital, where they saw the obesity specialist team comprising a paediatrician and a paediatric dietician who specialise in childhood obesity and weight management. Prior to the appointment, researchers extracted clinically-relevant information about the child and family from the baseline questionnaire, including family history, medical history, daily diet, physical activity and sedentary activities, and scored multi-item scales (see Additional file 1). These data were entered into a summary, with abnormal values flagged, in order to both save time on history-taking and to provide additional information that would not normally be available during a single first clinical consultation (see completed example Additional file 1). This allowed the team to devote more consultation time exploring lifestyle modification, rather than primarily information gathering.

At the appointment, a researcher first measured the child’s height, weight and percentage of truncal fat. The paediatrician then interviewed the child and family, taking a clinical history and examining the child using a standard protocol to identify possible causes and co-morbidities of obesity. The dietician then undertook a detailed dietary history and outlined general principles of healthy eating, offering targeted advice based on the child and family’s eating patterns. Physical and sedentary activities were assessed and, together, the paediatrician and dietician then discussed the lifestyle changes required that would most likely assist in successful weight management for the child. This advice focussed on family change and support, in accordance with research showing beneficial results to the child when the parents are involved [32], and is consistent with current recommendations that, for most obese children, BMI reduction is best achieved by maintaining, rather than losing, weight as the child grows [33]. Details of the specialist consultation, including the clinical summary and pathology results (if applicable) and an initial care plan, were then entered into the shared-care software.

If clinically indicated, parents/guardians were asked to bring their child to the Pathology Department at the Royal Children’s Hospital within the next 2–3 weeks for standard metabolic tests such as a check of thyroid function. These results were also entered into the shared-care software so the GP could access them.

GP consultations

After the specialist appointment, a follow-up appointment with the child’s GP was scheduled by the research team. Both the specialist and research team encouraged families to see their GP for regular (i.e. every 4–8 weeks) weight management consultations for a year following the specialist consultation. Information from the obesity specialists was available to all GPs via the shared-care software, including the family’s customised care plan.

The weight management GP consultations were designed to: 1) review lifestyle and BMI progress; 2) identify and solve problems where possible; and 3) set new goals using brief solution-focused techniques. The obesity specialists were available to the GP on an ‘as-needed’ basis throughout the trial. At the 6-month point, the obesity specialists formally reviewed each family’s progress using the synchronised software, with a focus on solutions and guidance for GPs. Each family’s review generated a one-page letter that was sent to the treating GP.

Control arm

Participants in the usual-care (control) arm were not offered an obesity clinic appointment or identified as being in the trial to their GP. Parents were informed that they were free to seek assistance with their GP or with any other service. Should they present to their GP, the GP would be able to implement their usual clinical care and utilise skills gained in the training process, but they were not able to access the shared-care software to track progress, educational resources or access support from the obesity specialists regarding these patients.

Measures and training

Table 1 summarises all outcome measures for the trial, with the primary outcome being BMI expressed as kg/m2[33]. All outcomes will be measured at 15 months post-randomisation, equating to approximately 12 months after the clinical consultation for the intervention children.

Table 1 Primary and secondary outcome measures for the HopSCOTCH trial

All researchers involved in baseline and outcome measurements were trained by researchers experienced in conducting similar measurements in the community from other research trials and longitudinal studies in childhood obesity. Researchers were trained at a single one-hour session where each measurement was demonstrated and repeatedly practised to ensure accuracy, competency, and reliability.

Process evaluation

Process evaluation will be completed by parents and GPs. The items will document extent to which interventions were implemented, acceptability, barriers to attendance, and perceived harms and benefits. Parents will report other assistance received (source, type, intensity) for their children’s weight status.

Economic evaluation

If the intervention is effective, we will proceed to a full economic evaluation. This will comprise !analysis conducted from both societal and health care perspectives [34], as interventions cost-effective from a health care perspective can add substantially to family costs [35]. This will compare any incremental costs of the intervention (over the control group) to all incremental outcomes detailed above. Resources used in intervention design, development and delivery have been prospectively documented via research team records, the trial database, hospital and general practice records, and parental report and valued using existing unit cost estimates. Uncertainty in the cost and outcome data and sensitivity of results to the evaluation methods chosen will be tested through extensive sensitivity analyses.

Sample size

The target sample size was calculated to detect a mean difference of 0.3 BMI z-score units at 15 months (comparable to published mean changes seen from specialist obesity clinics[4]) between arms with 80% power at 5% (2 sided) level of significance. Allowing for 10% loss to follow-up, we aimed to recruit 172 children.

Data Analysis

Analyses will be by ‘intention to treat’ at the level of the individual child. Linear regression will be used to compare quantitative outcomes between the trial groups adjusting for confounders and baseline measures of the outcomes where these are available, using an analysis of covariance approach. Logistic regression will be used to compare dichotomous outcomes.

Confounders selected a priori for multivariable models will include child sex, age at randomisation, and family socioeconomic status, which will be assigned according to postal code of residence using the Index of Relative Socioeconomic Disadvantage (mean 1000, s.d. 100) from the Australian Bureau of Statistics census-based Socio-Economic Indexes for Areas (SEIFA) [36].


Without more effective evidence-based treatments to reduce the childhood obesity, we are heading into uncharted territory. Large numbers of obese children are now reaching adulthood, with yet-to-be-quantified impacts on obesity-related comorbidities such as diabetes, poor mental health, hypertension, heart disease and cancers - which would in turn lead to increased health services costs.

If effective, shared-care models for childhood obesity have the potential to offer obese children effective treatment that is easily accessible. Benefits would include increased general practitioner identification of childhood obesity; a shift in focus towards younger obese children (for whom treatment is more effective and secondary prevention of morbidity is still possible); and a model for sustainable, supported partnerships between primary and specialist care with substantially better results than the disappointing stand-alone primary care trials to date.

Author’s contributions

MW conceived the trial. KL participated in the coordination of the study and drafted the current manuscript, supervised by MW. MAS contributed to the study design, particularly the structure of the specialist obesity clinic. JG contributed to the study design, particularly the general practitioners involvement. KG contributed to the study design, particularly the structure of the specialist obesity clinic. CH contributed to the study design, particularly the general practitioners involvement. ZM contributed to the study design, particularly the structure of the specialist obesity clinic. EY participated in the coordination of the study and drafted the current manuscript, supervised by MW. MS contributed to the study design, particularly the software design and implementation. GW contributed to the study design, particularly the general practitioners involvement and the software development. All authors contributed, read and approved the final manuscript.



General practitioner


Centres for Disease Control


Body mass index


Pen Computer Systems Pty Ltd.


  1. Olds T, Maher C: Global trends in childhood overweight and obesity in developed countries. Childhood Obesity Prevention – International Research, Controversies and Interventions. Edited by: O’Dea J, Eriksen M. 2010, Oxford: Oxford University Press

    Google Scholar 

  2. Cretikos MA, Valenti L, Britt HC, Baur LA: General practice management of overweight and obesity in children and adolescents in Australia. Med Care. 2008, 46 (11): 1163-1169. 10.1097/MLR.0b013e318179259a.

    Article  PubMed  Google Scholar 

  3. Hiscock H, Roberts G, Efron D, Sewell JR, Bryson HE, Price AMH, Oberklaid F, South M, Wake MA: Children Attending Paediatricians Study: a national prospective audit of outpatient practice from the Australian Paediatric Research Network. Med J Aust. 2011, 194 (8): 392-397.

    PubMed  Google Scholar 

  4. Sabin MA, Ford A, Hunt L, Jamal R, Crowne EC, Shield JP: Which factors are associated with a successful outcome in a weight management programme for obese children?. J Eval Clin Pract. 2007, 13 (3): 364-368. 10.1111/j.1365-2753.2006.00706.x.

    Article  PubMed  Google Scholar 

  5. Reinehr T, Kiess W, Kapellen T, Andler W: Insulin sensitivity among obese children and adolescents, according to degree of weight loss. Pediatrics. 2004, 114 (6): 1569-1573. 10.1542/peds.2003-0649-F.

    Article  PubMed  Google Scholar 

  6. Hunt LP, Ford A, Sabin MA, Crowne EC, Shield JPH: Clinical measures of adiposity and percentage fat loss: which measure most accurately reflects fat loss and what should we aim for?. Arch Dis Child. 2007, 92 (5): 399-403. 10.1136/adc.2006.103986.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Reinehr T, Andler W: Changes in the atherogenic risk factor profile according to degree of weight loss. Arch Dis Child. 2004, 89 (5): 419-422. 10.1136/adc.2003.028803.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Moore H, Summerbell CD, Greenwood DC, Tovey P, Griffiths J, Henderson M, Hesketh K, Woolgar S, Adamson AJ: Improving management of obesity in primary care: cluster randomised trial. BMJ. 2003, 327 (7423): 1085-1088. 10.1136/bmj.327.7423.1085.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Whitlock EP, Williams SB, Gold R, Smith PR, Shipman SA: Screening and interventions for childhood overweight: a summary of evidence for the US Preventive Services Task Force. Pediatrics. 2005, 116 (1): Supplement: e125-144.

    Article  Google Scholar 

  10. Wake M, Baur LA, Gerner B, Gibbons K, Gold L, Gunn J, Levickis P, McCallum Z, Naughton G, Sanci L, et al: Outcomes and costs of primary care surveillance and intervention for overweight or obese children: the LEAP 2 randomised controlled trial. British Medical Journal. 2009, 339:

    Google Scholar 

  11. Schwartz RP, Hamre R, Dietz WH, Wasserman RC, Slora EJ, Myers EF, Sullivan S, Rockett H, Thoma KA, Dumitru G, et al: Office-based motivational interviewing to prevent childhood obesity - A feasibility study. Arch Pediatr Adolesc Med. 2007, 161 (5): 495-501. 10.1001/archpedi.161.5.495.

    Article  PubMed  Google Scholar 

  12. Taveras EM, Gortmaker SL, Hohman KH, Horan CM, Kleinman KP, Mitchell K, Price S, Prosser LA, Rifas-Shiman SL, Gillman MW: Randomized controlled trial to improve primary care to prevent and manage childhood obesity: The High Five for Kids Study. Arch Pediatr Adolesc Med. 2011, 165 (8): 714-722. 10.1001/archpediatrics.2011.44.

    Article  PubMed  Google Scholar 

  13. Wake M, Waters E, Salmon LA, Hesketh K: Parent-reported health status of overweight and obese Australian primary school children: a cross-sectional population survey. Int J Obes. 2002, 26: 717-724. 10.1038/sj.ijo.0801974.

    Article  CAS  Google Scholar 

  14. McCallum Z, Wake M, Gerner B, Baur L, Gibbons K, Gold L, Gunn J, Harris C, Naughton G, Riess C, et al: Outcome data from the LEAP (Live, Eat and Play) trial: a randomized controlled trial of a primary care intervention for childhood overweight/mild obesity. Int J Obes. 2006, 31: 630-636.

    Google Scholar 

  15. Waters EB, Haby MM, Wake M, Salmon LA: Public health and preventive healthcare in children: current practices of Victorian GPs and barriers to participation. Med J Aust. 2000, 173 (2): 68-71.

    CAS  PubMed  Google Scholar 

  16. McCallum Z, Wake M, Gerner B, Harris C, Gibbons K, Gunn J, Waters E, Baur LA: Can Australian general practitioners tackle childhood overweight/obesity? Methods and processes from the LEAP (Live, Eat and Play) randomized controlled trial. J Paediatr Child Health. 2005, 41 (9–10): 488-494.

    Article  PubMed  Google Scholar 

  17. Nielsen JD, Palshof T, Mainz J, Jensen AB, Olesen F: Randomised controlled trial of a shared care programme for newly referred cancer patients: bridging the gap between general practice and hospital. Qual Saf Health Care. 2003, 12 (4): 263-272. 10.1136/qhc.12.4.263.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Symmons D, Tricker K, Roberts C, Davies L, Dawes P, Scott DL: The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis. Health Technology Assessment. 2005, 9 (34): III-+.

    Article  CAS  PubMed  Google Scholar 

  19. McHugh F, Lindsay GM, Hanlon P, Hutton I, Brown MR, Morrison C, Wheatley DJ: Nurse led shared care for patients on the waiting list for coronary artery bypass surgery: a randomised controlled trial. Heart. 2001, 86 (3): 317-323. 10.1136/heart.86.3.317.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Shields N, Turnbull D, Reid M, Holmes A, McGinley M, Smith LN: Satisfaction with midwife-managed care in different time periods: a randomised controlled trial of 1299 women. Midwifery. 1998, 14 (2): 85-93. 10.1016/S0266-6138(98)90003-1.

    Article  CAS  PubMed  Google Scholar 

  21. Stuart W, Smellie A: Do we need lipid clinics? Shifting the balance between secondary and primary care. Ann Clin Biochem. 2005, 42: 463-467. 10.1258/000456305774538201.

    Article  CAS  PubMed  Google Scholar 

  22. Bodenheimer T, Grumbach K: Electronic technology - A spark to revitalize primary care?. JAMA. 2003, 290 (2): 259-264. 10.1001/jama.290.2.259.

    Article  PubMed  Google Scholar 

  23. Cornerstones of e-health given green light. []

  24. McInnes DK, Saltman DC, Kidd MR: General practitioners' use of computers for prescribing and electronic health records: results from a national survey. Med J Aust. 2006, 185 (2): 88-91.

    PubMed  Google Scholar 

  25. Baker A, Lafata J, Ward R, Whitehouse F, Divine G: A web-based diabetes care management support system. Joint Comm J Qual Improv. 2001, 27 (4): 179-190.

    CAS  Google Scholar 

  26. Cohen E, Uleryk E, Jasuja M, Parkin PC: An absence of pediatric randomized controlled trials in general medical journals, 1985–2004. J Clin Epidemiol. 2007, 60 (2): 118-123. 10.1016/j.jclinepi.2006.03.015.

    Article  PubMed  Google Scholar 

  27. Horn SD, DeJong G, Ryser DK, Veazie PJ, Teraoka J: Another look at observational studies in rehabilitation research: Going beyond the holy grail of the randomized controlled trial. Arch Phys Med Rehabil. 2005, 86 (12): S8-S15. 10.1016/j.apmr.2005.08.116.

    Article  PubMed  Google Scholar 

  28. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL: CDC growth charts: United States. Adv Data. 2000, 314: 1-27.

    PubMed  Google Scholar 

  29. McCallum Z, Wake M, Baur L, Team L: The Leap (live, eat and play) trial: Results of a randomized controlled trial of a primary care intervention for childhood overweight/mild obesity. Obes Res. 2004, 12: A15-A16.

    Google Scholar 

  30. Prochaska JO, DiClemente CC: Stages of change in the modification of problem behavior. Prog Behav Modif. 1992, 28: 183-218.

    CAS  PubMed  Google Scholar 

  31. Turnell A, Hopwood L: Solution-focused brief therapy. Case Studies in Brief and Family Therapy. 1994, 8 (2): 39-51.

    Google Scholar 

  32. Summerbell CD, Ashton V, Campbell KJ, Edmunds L, Kelly S, Waters E: Interventions for treating obesity in children. Cochrane Database Syst Rev. 2003, 3: CD001872-

    PubMed  Google Scholar 

  33. National Health and Medical Research Council: Clinical Practice Guidelines for the Management of Overweight and Obesity in Children and Adolescents. 2003

    Google Scholar 

  34. Drummond M, Sculpher M, Torrance G, O'Brien B, Stoddart G: Methods for the economic evaluation of health care programs. 2005, Oxford: Oxford University Press, 3

    Google Scholar 

  35. Gibbard D, Coglan L, MacDonald J: Cost-effectiveness analysis of current practice and parent intervention for children under 3 years presenting with expressive language delay. Int J Lang Commun Disord. 2004, 39 (2): 229-244. 10.1080/13682820310001618839.

    Article  PubMed  Google Scholar 

  36. Australian Bureau of Statistics: Census of Population and Housing: Socio-Economic Indexes for Areas (SEIFA), Australia - Data only , 2006. 2008, Canberra: ABS

    Google Scholar 

  37. Schaefer F, Georgi M, Zieger A, Scharer K: Usefulness of bioelectric impedance and skinfold measurements in predicting fat-free masss derived from total-body potassium in children. Pediatr Res. 1994, 35 (5): 617-624. 10.1203/00006450-199405000-00016.

    Article  CAS  PubMed  Google Scholar 

  38. Varni JW, Burwinkle TM, Seid M, Skarr D: The PedsQL (TM) 4.0 as a pediatric population health measure: Feasibility, reliability, and validity. Ambul Pediatr. 2003, 3 (6): 329-341. 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2.

    Article  PubMed  Google Scholar 

  39. Collins ME: Body Figure Perceptions and Preferences Among Preadolescent Children. Int J Eat Disord. 1991, 102 (2): 199-208.

    Article  Google Scholar 

  40. Goodman R: The Strengths and Difficulties Questionnaire: a research note. J Child Psychol Psychiatry. 1997, 38 (5): 581-586. 10.1111/j.1469-7610.1997.tb01545.x.

    Article  CAS  PubMed  Google Scholar 

  41. Bandura A: Self-efficacy - toward a unifying theory of behavioural change. Psychol Rev. 1977, 84 (2): 191-215.

    Article  CAS  PubMed  Google Scholar 

Pre-publication history

Download references

Acknowledgements and funding

The trial is funded by the Australian National Health and Medical Research Council (NHMRC Project Grant 491212). We would like to thank all the children, parents, obesity specialists (MAS, ZM, KG, Michele Campbell and Ms Elisha Matthews), GPs and practice staff who took part in the trial. We also gratefully acknowledge the input and support of PCS and Mr Michael Stringer of Knowsys in developing, deploying and managing the shared-care software. MW was part-funded by NHMRC Population Health Career Development Grants 284556 and 546405 and MAS by NHMRC Professional Training Fellowship 1012201. Murdoch Childrens Research Institute is supported by the Victorian Government’s Operational Infrastructure Support Program.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Melissa Wake.

Additional information

Competing interests

All authors declare that they and their spouses, partners or children have no financial and non-financial relationships or interests that may be relevant to the submitted work. The authors declare they have no competing interests.

Electronic supplementary material

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.

Authors’ original file for figure 1

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Wake, M., Lycett, K., Sabin, M.A. et al. A shared-care model of obesity treatment for 3–10 year old children: Protocol for the HopSCOTCH randomised controlled trial. BMC Pediatr 12, 39 (2012).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: